NIOPEG
Google image searchProduct monograph
Active ingredient
pegfilgrastim, 6 MG/0.6 ML
DIN: 02546973
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PREFILLED SYRINGE
Schedule: Prescription / Schedule D
Company: NORA PHARMA INC
Date: 12-FEB-2025
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AA — Colony stimulating factors (ATC, ATC/DDD)
- L03AA13 — PEGFILGRASTIM (ATC/DDD)
Reference brand drug: Neulasta, Fulphila, Lapelga, Nyvepria, Ziextenzo
